HEADER HYDROLASE/HYDROLASE INHIBITOR 14-JUL-10 3NXN TITLE X-RAY STRUCTURE OF ESTER CHEMICAL ANALOGUE 'COVALENT DIMER' [ILE50,O- TITLE 2 ILE50']HIV-1 PROTEASE COMPLEXED WITH KVS-1 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEASE COVALENT DIMER; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.23.16; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: CHEMICAL PROTEIN SYNTHESIS KEYWDS BETA-BARREL, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR V.Y.TORBEEV,S.B.H.KENT REVDAT 3 31-JUL-19 3NXN 1 COMPND FORMUL LINK REVDAT 2 11-JAN-12 3NXN 1 JRNL REVDAT 1 02-NOV-11 3NXN 0 JRNL AUTH V.Y.TORBEEV,H.RAGHURAMAN,D.HAMELBERG,M.TONELLI,W.M.WESTLER, JRNL AUTH 2 E.PEROZO,S.B.KENT JRNL TITL PROTEIN CONFORMATIONAL DYNAMICS IN THE MECHANISM OF HIV-1 JRNL TITL 2 PROTEASE CATALYSIS. JRNL REF PROC.NATL.ACAD.SCI.USA V. 108 20982 2011 JRNL REFN ISSN 0027-8424 JRNL PMID 22158985 JRNL DOI 10.1073/PNAS.1111202108 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 16574 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 885 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1141 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.1980 REMARK 3 BIN FREE R VALUE SET COUNT : 50 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1543 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 98 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.29 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.95000 REMARK 3 B22 (A**2) : 0.11000 REMARK 3 B33 (A**2) : -1.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.133 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.091 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.822 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.945 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1639 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1094 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2216 ; 1.807 ; 2.005 REMARK 3 BOND ANGLES OTHERS (DEGREES): 2693 ; 0.928 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 199 ; 6.993 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 59 ;44.064 ;24.915 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 284 ;13.452 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;14.425 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 255 ; 0.112 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1735 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 275 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 246 ; 0.210 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1101 ; 0.206 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 759 ; 0.178 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 896 ; 0.093 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 58 ; 0.126 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 10 ; 0.199 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 35 ; 0.168 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.211 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1049 ; 1.170 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 429 ; 0.329 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1655 ; 1.834 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 659 ; 2.584 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 558 ; 4.163 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 1 A 202 REMARK 3 ORIGIN FOR THE GROUP (A): 5.0436 1.1682 18.3173 REMARK 3 T TENSOR REMARK 3 T11: -0.0379 T22: -0.0560 REMARK 3 T33: -0.0504 T12: -0.0137 REMARK 3 T13: -0.0032 T23: -0.0018 REMARK 3 L TENSOR REMARK 3 L11: 1.4158 L22: 0.7918 REMARK 3 L33: 0.8416 L12: -0.3106 REMARK 3 L13: 0.5847 L23: 0.1527 REMARK 3 S TENSOR REMARK 3 S11: -0.0357 S12: 0.0712 S13: 0.0111 REMARK 3 S21: -0.0195 S22: 0.0522 S23: -0.0021 REMARK 3 S31: -0.0241 S32: 0.0687 S33: -0.0164 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 204 A 204 REMARK 3 ORIGIN FOR THE GROUP (A): 5.4503 -0.8046 13.1496 REMARK 3 T TENSOR REMARK 3 T11: -0.0330 T22: -0.0058 REMARK 3 T33: -0.0353 T12: -0.0185 REMARK 3 T13: 0.0207 T23: -0.0185 REMARK 3 L TENSOR REMARK 3 L11: 16.9913 L22: 12.9251 REMARK 3 L33: 25.8384 L12: -13.2512 REMARK 3 L13: 18.4757 L23: -15.9547 REMARK 3 S TENSOR REMARK 3 S11: 0.1334 S12: 0.2966 S13: 0.0612 REMARK 3 S21: -0.6249 S22: -0.4069 S23: -0.2749 REMARK 3 S31: 0.4377 S32: 0.6479 S33: 0.2735 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3NXN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JAN-11. REMARK 100 THE DEPOSITION ID IS D_1000060407. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 14-BM-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.90020 REMARK 200 MONOCHROMATOR : BENT GE(111) MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17520 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 102.900 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.40400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.510 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.86 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M CITRATE, 0.2 M SODIUM PHOSPHATE, REMARK 280 30% (W/V) AMMONIUM SULFATE, 10% (V/V) DMSO, PH 6.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.93550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.82000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.82200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.82000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.93550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.82200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N~2~-[(2R,5S)-5-({(2S,3S)-2-[(N-ACETYL-L-THREONYL) REMARK 630 AMINO]-3-METHYLPENT-4-ENOYL}AMINO)-2-BUTYL-4,4-DIHYDROXYNONANOYL]- REMARK 630 L-GLUTAMINYL-L-ARGININAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 KVS A 204 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ACE THR ILE NLH GLN ARG NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE KVS A 204 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 504 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3NWX RELATED DB: PDB REMARK 900 RELATED ID: 3NWQ RELATED DB: PDB REMARK 900 RELATED ID: 3NXE RELATED DB: PDB REMARK 900 RELATED ID: 3HAU RELATED DB: PDB REMARK 900 RELATED ID: 3HDK RELATED DB: PDB REMARK 900 RELATED ID: 3HLO RELATED DB: PDB REMARK 900 RELATED ID: 3NYG RELATED DB: PDB DBREF 3NXN A 1 203 PDB 3NXN 3NXN 1 203 SEQRES 1 A 203 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 2 A 203 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 3 A 203 GLY ALA ASP ASP THR VAL ILE GLU GLU NLE ASN LEU PRO SEQRES 4 A 203 GLY YCM TRP LYS PRO LYS NLE ILE GLY GLY ILE GLY GLY SEQRES 5 A 203 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU SEQRES 6 A 203 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 7 A 203 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 8 A 203 GLN ILE GLY ABA THR LEU ASN PHE YCM GLY GLY GLY GLY SEQRES 9 A 203 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE SEQRES 10 A 203 ARG ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR SEQRES 11 A 203 GLY ALA ASP ASP THR VAL ILE GLU GLU NLE ASN LEU PRO SEQRES 12 A 203 GLY YCM TRP LYS PRO LYS NLE ILE GLY GLY OIL GLY GLY SEQRES 13 A 203 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE PRO VAL GLU SEQRES 14 A 203 ILE ABA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY SEQRES 15 A 203 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR SEQRES 16 A 203 GLN ILE GLY ABA THR LEU ASN PHE MODRES 3NXN NLE A 36 LEU NORLEUCINE MODRES 3NXN YCM A 41 CYS S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE MODRES 3NXN NLE A 46 LEU NORLEUCINE MODRES 3NXN ABA A 67 ALA ALPHA-AMINOBUTYRIC ACID MODRES 3NXN ABA A 95 ALA ALPHA-AMINOBUTYRIC ACID MODRES 3NXN YCM A 100 CYS S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE MODRES 3NXN NLE A 140 LEU NORLEUCINE MODRES 3NXN YCM A 145 CYS S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE MODRES 3NXN NLE A 150 LEU NORLEUCINE MODRES 3NXN ABA A 171 ALA ALPHA-AMINOBUTYRIC ACID MODRES 3NXN ABA A 199 ALA ALPHA-AMINOBUTYRIC ACID HET NLE A 36 8 HET YCM A 41 10 HET NLE A 46 8 HET ABA A 67 6 HET ABA A 95 6 HET YCM A 100 10 HET NLE A 140 8 HET YCM A 145 10 HET NLE A 150 8 HET OIL A 154 8 HET ABA A 171 6 HET ABA A 199 6 HET KVS A 204 56 HET SO4 A 501 5 HET SO4 A 502 5 HET SO4 A 503 5 HET SO4 A 504 5 HETNAM NLE NORLEUCINE HETNAM YCM S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM OIL (2S,3S)-2-HYDROXY-3-METHYLPENTANOIC ACID HETNAM KVS N~2~-[(2R,5S)-5-({(2S,3S)-2-[(N-ACETYL-L-THREONYL) HETNAM 2 KVS AMINO]-3-METHYLPENT-4-ENOYL}AMINO)-2-BUTYL-4,4- HETNAM 3 KVS DIHYDROXYNONANOYL]-L-GLUTAMINYL-L-ARGININAMIDE HETNAM SO4 SULFATE ION HETSYN YCM CYSTEINE-S-ACETAMIDE FORMUL 1 NLE 4(C6 H13 N O2) FORMUL 1 YCM 3(C5 H10 N2 O3 S) FORMUL 1 ABA 4(C4 H9 N O2) FORMUL 1 OIL C6 H12 O3 FORMUL 2 KVS C36 H68 N10 O10 FORMUL 3 SO4 4(O4 S 2-) FORMUL 7 HOH *98(H2 O) HELIX 1 1 GLY A 86 THR A 91 1 6 HELIX 2 2 GLY A 190 THR A 195 1 6 SHEET 1 A 4 GLN A 2 ILE A 3 0 SHEET 2 A 4 ABA A 199 ASN A 202 -1 O LEU A 201 N ILE A 3 SHEET 3 A 4 THR A 96 PHE A 99 -1 N THR A 96 O ASN A 202 SHEET 4 A 4 GLN A 106 ILE A 107 -1 O ILE A 107 N LEU A 97 SHEET 1 B 8 TRP A 42 GLY A 49 0 SHEET 2 B 8 GLY A 52 ILE A 66 -1 O GLN A 58 N LYS A 43 SHEET 3 B 8 HIS A 69 VAL A 77 -1 O HIS A 69 N ILE A 66 SHEET 4 B 8 VAL A 32 ILE A 33 1 N ILE A 33 O LEU A 76 SHEET 5 B 8 ILE A 84 ILE A 85 -1 O ILE A 84 N VAL A 32 SHEET 6 B 8 GLN A 18 LEU A 24 1 N LEU A 23 O ILE A 85 SHEET 7 B 8 LEU A 10 ILE A 15 -1 N ILE A 15 O GLN A 18 SHEET 8 B 8 GLY A 52 ILE A 66 -1 O GLU A 65 N ARG A 14 SHEET 1 C 8 LYS A 147 GLY A 152 0 SHEET 2 C 8 GLY A 155 ILE A 170 -1 O GLN A 162 N LYS A 147 SHEET 3 C 8 HIS A 173 VAL A 181 -1 O VAL A 179 N TYR A 163 SHEET 4 C 8 VAL A 136 ILE A 137 1 N ILE A 137 O LEU A 180 SHEET 5 C 8 ILE A 188 ILE A 188 -1 O ILE A 188 N VAL A 136 SHEET 6 C 8 GLN A 122 LEU A 127 1 N LEU A 127 O ILE A 188 SHEET 7 C 8 LEU A 114 ILE A 119 -1 N ILE A 117 O LYS A 124 SHEET 8 C 8 GLY A 155 ILE A 170 -1 O GLU A 169 N ARG A 118 LINK C GLU A 35 N NLE A 36 1555 1555 1.33 LINK C NLE A 36 N ASN A 37 1555 1555 1.34 LINK C GLY A 40 N YCM A 41 1555 1555 1.34 LINK C YCM A 41 N TRP A 42 1555 1555 1.33 LINK C LYS A 45 N NLE A 46 1555 1555 1.33 LINK C NLE A 46 N ILE A 47 1555 1555 1.33 LINK C ILE A 66 N ABA A 67 1555 1555 1.33 LINK C ABA A 67 N GLY A 68 1555 1555 1.32 LINK C GLY A 94 N ABA A 95 1555 1555 1.34 LINK C ABA A 95 N THR A 96 1555 1555 1.32 LINK C PHE A 99 N YCM A 100 1555 1555 1.34 LINK C YCM A 100 N GLY A 101 1555 1555 1.33 LINK C GLU A 139 N NLE A 140 1555 1555 1.33 LINK C NLE A 140 N ASN A 141 1555 1555 1.34 LINK C GLY A 144 N YCM A 145 1555 1555 1.32 LINK C YCM A 145 N TRP A 146 1555 1555 1.31 LINK C LYS A 149 N NLE A 150 1555 1555 1.32 LINK C NLE A 150 N ILE A 151 1555 1555 1.34 LINK C GLY A 153 O1 OIL A 154 1555 1555 1.27 LINK C OIL A 154 N GLY A 155 1555 1555 1.33 LINK C ILE A 170 N ABA A 171 1555 1555 1.32 LINK C ABA A 171 N GLY A 172 1555 1555 1.31 LINK C GLY A 198 N ABA A 199 1555 1555 1.33 LINK C ABA A 199 N THR A 200 1555 1555 1.34 SITE 1 AC1 23 ARG A 8 ASP A 25 GLY A 27 ALA A 28 SITE 2 AC1 23 ASP A 29 GLY A 48 GLY A 49 ILE A 50 SITE 3 AC1 23 VAL A 82 ARG A 112 ASP A 129 GLY A 131 SITE 4 AC1 23 ALA A 132 ASP A 133 ASP A 134 ILE A 151 SITE 5 AC1 23 GLY A 152 GLY A 153 VAL A 186 HOH A 301 SITE 6 AC1 23 HOH A 303 HOH A 333 HOH A 334 SITE 1 AC2 5 LEU A 114 GLU A 125 ALA A 126 VAL A 186 SITE 2 AC2 5 ASN A 187 SITE 1 AC3 7 ARG A 14 GLY A 16 GLY A 17 ARG A 118 SITE 2 AC3 7 HOH A 323 HOH A 338 HOH A 382 SITE 1 AC4 3 LYS A 45 NLE A 46 HOH A 313 SITE 1 AC5 8 THR A 116 ILE A 117 ARG A 118 TRP A 146 SITE 2 AC5 8 GLU A 169 ILE A 170 ABA A 171 GLY A 172 CRYST1 51.871 57.644 61.640 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019279 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017348 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016223 0.00000 MASTER 317 0 17 2 20 0 13 6 0 0 0 16 END